Vertex Pharmaceuticals
VRTX
VRTX
947 hedge funds and large institutions have $65.9B invested in Vertex Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 92 funds opening new positions, 403 increasing their positions, 319 reducing their positions, and 95 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
947
Holders Change
-12
Holders Change %
-1.25%
% of All Funds
19.16%
Holding in Top 10
20
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-25.93%
% of All Funds
0.4%
New
92
Increased
403
Reduced
319
Closed
95
Calls
$237M
Puts
$279M
Net Calls
-$42.1M
Net Calls Change
-$44.1M
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$248M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$236M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
+$221M |
| 4 |
Goldman Sachs
New York
|
+$148M |
| 5 |
HM
HealthCor Management
New York
|
+$91.6M |
Top Sellers
| 1 |
Capital World Investors
Los Angeles,
California
|
-$307M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$225M |
| 3 |
Jennison Associates
New York
|
-$220M |
| 4 |
Renaissance Technologies
New York
|
-$156M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$121M |
